| 1 |
Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism [J]. Kidney Int,2013,84(6):1096-1107.
|
| 2 |
Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int, 2008, 73(4):391-398.
|
| 3 |
Chan M, Kelly J, Batterham M, et al. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values,at initiation of dialysis are independent predictors of mortality:a 10-year clinical cohort study[J]. J Ren Nutr,2012,22(6):547-557.
|
| 4 |
Leinig CE, Moraes T, Ribeiro S, et al. Predictive value of malnutrition markers for mortality in peritoneal dialysis patients [J].J Ren Nutr,2011,21(2):176-183.
|
| 5 |
Tonbul HZ, Demir M, Altintepe L, et al. Malnutritioninflammation-atherosclerosis ( MIA ) syndrome components in hemodialysis and peritoneal dialysis patients [J]. Ren Fail, 2006,28(4):287-294.
|
| 6 |
Afsar B, Sezer S, Elsurer R, et al. Malnutrition-inflammation score in peritoneal dialysis: growing reliability [J]. Perit Dial Int,2008,28(2):207.
|
| 7 |
Mitch WE. Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease [J]. J Ren Nutr,2007,17(1):66-69.
|
| 8 |
Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM) [J]. J Ren Nutr,2013,23(2):77-90.
|
| 9 |
Vegine PM, Fernandes AC, Torres MR, et al. Assessment of methods to identify protein-energy wasting in patients on hemodialysis[J]. J Bras Nefrol,2011,33(1):55-61.
|
| 10 |
Bonanni A, Mannucci I, Verzola D, et al. Protein-energy wasting and mortality in chronic kidney disease [J]. Int J Environ Res Public Health,2011,8(5):1631-1654.
|
| 11 |
Du J, Hu Z, Mitch WE. Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions [J]. Eur J Clin Invest,2005,35(3):157-163.
|
| 12 |
Siew ED, Pupim LB, Majchrzak KM, et al. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients [J]. Kidney Int, 2007, 71(2):146-152.
|
| 13 |
Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states [J]. J Am Soc Nephrol,2006,17(7):1807-1819.
|
| 14 |
Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy [J]. Cell,2004,117(3):399-412.
|
| 15 |
Lecker SH, Mitch WE. Proteolysis by the ubiquitin-proteasome system and kidney disease [J]. J Am Soc Nephrol,2011,22(5):821-824.
|
| 16 |
Rasic-Milutinovic Z, Perunicic-Pekovic G, Ristic-Medic D, et al.Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis[J]. Gen Physiol Biophys,2009,28 Spec No:184-189.
|
| 17 |
Price SR, Gooch JL, Donaldson SK, et al. Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling[J]. J Ren Nutr,2010,20(5 Suppl): S24-S28.
|
| 18 |
Wang XH, Zhang L, Mitch WE, et al. Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity [J]. J Biol Chem,2010,285(28):21249-21257.
|
| 19 |
Boivin MA, Battah SI, Dominic EA, et al. Activation of caspase-3 in the skeletal muscle during haemodialysis [J]. Eur J Clin Invest,2010,40(10):903-910.
|
| 20 |
Mak RH, Rotwein P. Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation [J].Kidney Int,2006,70(3):410-412.
|
| 21 |
Gilson H, Schakman O, Combaret L, et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy[J]. Endocrinology,2007,148(1):452-460.
|
| 22 |
Hulmi JJ, Silvennoinen M, Lehti M, et al. Altered REDD1,myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocininduced diabetic muscle atrophy [J]. Am J Physiol Endocrinol Metab,2012,302(3): E307-E315.
|
| 23 |
Zhang L, Rajan V, Lin E, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease [J]. FASEB J, 2011, 25(5):1653-1663.
|
| 24 |
Goodman CA, Mcnally RM, Hoffmann FM, et al. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo [J]. Mol Endocrinol, 2013, 27(11):1946-1957.
|
| 25 |
Langen RC, Schols AM, Kelders MC, et al. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB [J]. FASEB J,2001,15(7):1169-1180.
|
| 26 |
Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy [J]. J Mol Med (Berl), 2008, 86(10):1113-1126.
|
| 27 |
Leal VO, Moraes C,Stockler-Pinto MB,et al. Is a body mass index of 23 kg/m2 a reliable marker of protein-energy wasting in hemodialysis patients? [J]. Nutrition,2012,28(10):973-977.
|
| 28 |
Brommage D. The nutrition guidelines: where do we go from here?[J]. J Ren Nutr,2006,16(3):288-289.
|
| 29 |
Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population:time dependency, longitudinal changes and population-attributable fraction [J]. Nephrol Dial Transplant,2005,20(9):1880-1888.
|
| 30 |
Lopes AA, Bragg-Gresham JL, Elder SJ, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J]. J Ren Nutr,2010,20(4):224-234.
|
| 31 |
Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutritioninflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients[J]. Am J Kidney Dis,2001,38(6):1251-1263.
|
| 32 |
Rambod M, Kovesdy CP, Kalantar-Zadeh K. Malnutrition-Inflammation Score for risk stratification of patients with CKD: is it the promised gold standard? [J]. Nat Clin Pract Nephrol, 2008, 4(7):354-355.
|
| 33 |
KDOQI Work Group. KDOQI clinical practice guideline for nutrition in children with CKD:2008 update. executive summary [J]. Am J Kidney Dis,2009,53(3 Suppl 2): S11-S104.
|
| 34 |
Fouque D, Aparicio M. Eleven reasons to control the protein intake of patients with chronic kidney disease [J]. Nat Clin Pract Nephrol,2007,3(7):383-392.
|
| 35 |
Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study [J]. Am J Kidney Dis,2007,49(5):569-580.
|
| 36 |
Greene JH. The new CKD nutrition practice guidelines[J]. Nephrol News Issues,2011,25(4):22.
|
| 37 |
Fouque D, Pelletier S, Guebre-Egziabher F. Have recommended protein and phosphate intake recently changed in maintenance hemodialysis? [J]. J Ren Nutr,2011,21(1):35-38.
|
| 38 |
Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition [J]. Nephrol Dial Transplant,2007,22 (Suppl 2): ii45-ii87.
|
| 39 |
Dukkipati R, Kalantar-Zadeh K, Kopple JD. Is there a role for intradialytic parenteral nutrition? A review of the evidence [J]. Am J Kidney Dis,2010,55(2):352-364.
|
| 40 |
Galland R, Traeger J, Arkouche W, et al. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients [J].Kidney Int,2001,60(4):1555-1560.
|
| 41 |
Kaysen GA, Greene T, Larive B, et al. The effect of frequent hemodialysis on nutrition and body composition: frequent hemodialysis network trial [J]. Kidney Int,2012,82(1):90-99.
|
| 42 |
Susantitaphong P, Riella C, Jaber B L. Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis [J]. Nephrol Dial Transplant, 2013,28(2):438-446.
|
| 43 |
Feldt-Rasmussen B, Lange M, Sulowicz W, et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk [J]. J Am Soc Nephrol,2007,18(7):2161-2171.
|
| 44 |
Kopple JD, Cheung AK, Christiansen JS, etal.OPPORTUNITYTM: a large-scale randomized clinical trial of growth hormone in hemodialysis patients [J]. Nephrol Dial Transplant,2011,26(12):4095-4103.
|
| 45 |
Han HQ, Mitch WE. Targeting the myostatin signaling pathway to treat muscle wasting diseases [J]. Curr Opin Support Palliat Care,2011,5(4):334-341.
|
| 46 |
Cheung WW, Ding W, Gunta SS, et al. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice [J]. J Am Soc Nephrol,2013, Oct 10[Epub ahead of print].
|